scorecardresearchLaurus Labs Share Price Live NSE, BSE, Today - Laurus Labs Stock Price

Laurus Labs

BSE: 540222 | NSE: LAURUSLABS | ISIN: INE947Q01028 | SECTOR: Biotechnology & Drugs

409.60 3.45 (0.85%)

01 Mar 2024, 10:11 (IST)
  • Open

    406.15
  • High

    412.00
  • Low

    405.05
  • Prev Close

    406.15
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    220.76B
  • Volume

    107.24K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    409.60

Promoter Pledge Holding - 0.01%

Promoter NameNo of SharesPercentage
NARASIMHA RAO SURYADEVARA60,0000.01%

Company Description

  • Biotechnology & Drugs
  • BSE

    540222
  • NSE

    LAURUSLABS
  • ISIN

    INE947Q01028

Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. The Company operates through three segments: Laurus Generics, Laurus Synthesis, and Laurus Bio. The Laurus Generics segment comprises API and FDF-Development, manufacture and sale of APIs and advanced intermediates and oral solid formulations/FDF. Laurus Synthesis segment comprises key starting materials (KSM), intermediates and APIs for new chemical entities (NCEs). Laurus Bio segment comprises recombinant products, animal origin free products for safer and viral free bio manufacturing. The Company operates through two geographical segments: Revenue from customers within India-Domestic, and Revenue from customers outside India-Exports. The Company sell its APIs in 56 countries.

Company Officers

  • Satyanarayana Chava

    Chief Executive Officer, Executive Director
  • Venkata Ravi Vantaram

    Chief Financial Officer, Executive Director
  • Thomas Versosky

    President - FDF, North America
  • Krishna Chava

    Executive Vice President - Head of Synthesis
  • V. Uma Maheswer Rao

    Executive Vice President - Chemical R&D
  • Srinivasa Suryadevara

    Executive Vice President - Manufacturing and Operations
  • Sita Ramaiah

    Senior Vice President - Finance
  • Narasimha Chava

    Senior Vice President - Human Resource
  • Rajaram Iyer

    Senior Vice President - Portfolio Management
  • Martyn James Peck

    Senior Vice President - Business Development